Discontinuation report ZOFRAN
Report ID | 189513 |
Drug Identification Number | 02213567 |
Brand name | ZOFRAN |
Common or Proper name | ZOFRAN FCT TABS 4 MG |
Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ONDANSETRON |
Strength(s) | 4MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 2X5 |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2023-05-30 |
Actual discontinuation date | 2023-04-22 |
Remaining supply date | 2023-12-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
Company contact information | customer.relations@novartis.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-04-13 | English | Compare |
v2 | 2023-04-13 | French | Compare |
v3 | 2023-04-13 | English | Compare |
v4 | 2023-04-13 | French | Compare |
v5 | 2023-05-08 | English | Compare |
v6 | 2023-05-08 | French | Compare |
Showing 1 to 6 of 6